Logo

American Heart Association

  1
  0


Final ID: WP170

Association of Workflow Metrics with Functional Outcomes in the SELECT2 trial

Abstract Body: Introduction: Faster reperfusion from initial presentation was associated with improved outcomes after endovascular thrombectomy(EVT) in patients with small core strokes. However, the relationship between time and different workflow metrics with outcomes in not well-established in patients with large strokes. We aimed to analyze the clinical workflow and time measures and their effect on overall procedure and functional outcomes from SELECT2 trial.
Methods: Patients enrolled in SELECT2 trial were stratified based on treatment arm and transfer status and various workflow metrics, both in-hospital and outside (limited to transferred patients) were compared and their effect on clinical outcomes were evaluated.
Results: Of 352 enrolled, 141 patients (72 EVT, 69 MM) presented directly to EVT-capable centers, whereas 211(106 EVT, 105 MM) were transferred from referral centers. Among patients presenting directly, no difference was observed between time from LKW to arrival(EVT:376.5(119.5-638)min vs MM:435(118-802)min,p=0.50), arrival to imaging acquisition(EVT:14(10-21)min vs MM:16.5(11-25)min,p=0.21) or time from imaging to randomization(EVT:55(40.5-72.5)min vs MM:64(44-84)min,p=0.083)-Fig1a. For patients transferred to EVT-capable centers, no difference was observed between treatment arms in time from LKW to arrival - EVT:418(63-757)min vs MM:313(87.5-713)min,p=0.77; time from arrival to imaging – EVT:12(3.5-24)min vs MM:13.5(10-20)min,p=0.12; time from imaging to departure – EVT:123.5(82-195)min vs MM:128.5(85-197.5)min,p=0.95; transit time to EVT center – EVT:39(21.5-67)min vs MM:38.5(25.5-67.5)min,p=0.73); time from imaging to randomization – EVT:43(21-70)min vs MM:39(21-68)min,p=0.96)-Fig1b. Longer procedure time was associated with worse mRS (aGenOR:0.92, 95%CI:0.87-0.96,p-value:0.001 for every 10min). Longer time from perfusion imaging to reperfusion was associated with worse mRS in both direct(aGenOR:0.99(0.99-1.00),p=0.003 for every 10min) and transferred patients(aGenOR:0.98(0.95-1.00),p=0.038 for every 10min) fig2, but Interfacility transfer times or other time metrics were not significantly associated with functional outcomes.

Conclusion: In large ischemic core infarct patients randomized in the SELECT2 trial, longer times from imaging to reperfusion and procedure time were associated with worse clinical outcomes after thrombectomy. Expedited and efficient workflow protocols at thrombectomy centers are vital to optimize outcomes in large core patients.
  • Jabbour, Pascal  ( THOMAS JEFFERSON UNIVERSITY , Philadelphia , Pennsylvania , United States )
  • Sitton, Clark  ( UT Houston McGovern Medical School , Houston , Texas , United States )
  • Churilov, Leonid  ( Royal Melbourne Hospital , Parkville , Victoria , Australia )
  • Hill, Michael  ( UNIVERSITY CALGARY , Calgary , Alberta , Canada )
  • Ribo, Marc  ( HOSPITAL VALL D HEBRON , Barcelona , Spain )
  • Campbell, Bruce  ( Royal Melbourne Hospital , Parkville , Victoria , Australia )
  • Gandhi, Chirag  ( Westchester Medical Center , Valhalla , New York , United States )
  • Tjoumakaris, Stavropoula  ( THOMAS JEFFERSON UNIVERSITY , Philadelphia , Pennsylvania , United States )
  • Sarraj, Amrou  ( University Hospitals Cleveland Med , Cleveland , Ohio , United States )
  • Al-mufti, Fawaz  ( Westchester Medical Center at New Y , Valhalla , New York , United States )
  • Hassan, Ameer  ( UTRGV - VALLEY BAPTIST MEDICAL CENT , Harlingen , Texas , United States )
  • Abraham, Michael  ( UNIVERSITY OF KANSAS HOSPITAL , Kansas City , Missouri , United States )
  • Hussain, Shazam  ( CLEVELAND CLINIC , Cleveland , Ohio , United States )
  • Ortega-gutierrez, Santiago  ( UNIVERSITY OF IOWA HOSPITALS , Iowa City , Iowa , United States )
  • Chen, Michael  ( Rush University Medical Center , Chicago , Illinois , United States )
  • Pujara, Deep  ( University Hospitals , Cleveland , Ohio , United States )
  • Johns, Hannah Tabitha  ( Royal Melbourne Hospital , Parkville , Victoria , Australia )
  • Author Disclosures:
    Pascal Jabbour: DO NOT have relevant financial relationships | clark sitton: DO NOT have relevant financial relationships | leonid churilov: DO NOT have relevant financial relationships | Michael Hill: DO have relevant financial relationships ; Consultant:Brainsgate Inc:Past (completed) ; Individual Stocks/Stock Options:Circle Inc:Active (exists now) ; Individual Stocks/Stock Options:Basking Bioscience:Active (exists now) ; Research Funding (PI or named investigator):Boehringer-Ingelheim:Active (exists now) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) ; Consultant:Diamedica Inc:Active (exists now) | Marc Ribo: DO NOT have relevant financial relationships | Bruce Campbell: DO NOT have relevant financial relationships | Chirag Gandhi: DO NOT have relevant financial relationships | Stavropoula Tjoumakaris: DO have relevant financial relationships ; Consultant:Microvention:Active (exists now) | Amrou Sarraj: DO have relevant financial relationships ; Research Funding (PI or named investigator):Stryker Neurovascular:Active (exists now) | Fawaz Al-Mufti: DO NOT have relevant financial relationships | Ameer Hassan: DO have relevant financial relationships ; Consultant:Medtronic, Microvention, Stryker, Penumbra, Cerenovus, Genentech, GE Healthcare, Scientia, Balt, Viz.ai , Insera therapeutics, Proximie, NeuroVasc, NovaSignal, Vesalio, Rapid Medical, Imperative Care, Galaxy Therapeutics, Route 92, Perfuze, CorTech, Shockwave and Xcath:Active (exists now) | Michael Abraham: DO have relevant financial relationships ; Consultant:Stryker Neurovascular:Active (exists now) ; Consultant:Q'Apel Medical:Active (exists now) | Shazam Hussain: DO have relevant financial relationships ; Independent Contractor:Cerenovus:Active (exists now) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) ; Independent Contractor:Rapid Medical :Active (exists now) ; Independent Contractor:Stryker :Active (exists now) ; Consultant:Kaneka:Active (exists now) | Santiago Ortega-Gutierrez: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Research Funding (PI or named investigator):Methinks:Active (exists now) ; Research Funding (PI or named investigator):Stryker:Active (exists now) ; Research Funding (PI or named investigator):MEdtronic:Active (exists now) ; Researcher:PCORI:Active (exists now) ; Research Funding (PI or named investigator):NIH:Active (exists now) ; Consultant:Stryker:Active (exists now) | Michael Chen: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Consultant:Cerenovus:Active (exists now) ; Consultant:Q'Apel:Active (exists now) ; Researcher:Kaneka:Active (exists now) ; Consultant:Penumbra:Active (exists now) ; Consultant:RapidPulse:Active (exists now) | Deep Pujara: DO NOT have relevant financial relationships | Hannah Tabitha Johns: DO NOT have relevant financial relationships
Meeting Info:
Session Info:

Health Services, Quality Improvement, and Patient-Centered Outcomes Posters I

Wednesday, 02/05/2025 , 07:00PM - 07:30PM

Poster Abstract Session

More abstracts from these authors:
Effect of Time on EVT Treatment Effect and Clinical Outcomes in Patients with Large Strokes: A Pre-Specified Analysis of SELECT2 Trial

Sarraj Amrou, Sitton Clark, Grotta James, Hill Michael, Ribo Marc, Campbell Bruce, Hassan Ameer, Abraham Michael, Hussain Shazam, Ortega-gutierrez Santiago, Chen Michael, Pujara Deep, Johns Hannah Tabitha, Churilov Leonid

Mediation of Successful Reperfusion Effect on Independent Ambulation Through Infarct Growth Reduction in Patients with Large Strokes: A Secondary Analysis of SELECT2 Trial

Sarraj Amrou, Grotta James, Ribo Marc, Sitton Clark, Hill Michael, Campbell Bruce, Pujara Deep, Churilov Leonid, Johns Hannah Tabitha, Hassan Ameer, Abraham Michael, Hussain Shazam, Chen Michael, Ortega-gutierrez Santiago

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)